Drug Profile


Alternative Names: Antiepilepsirine

Latest Information Update: 21 Mar 2007

Price : $50

At a glance

  • Originator Beijing Medical University; Nonindustrial source
  • Developer Nonindustrial source
  • Class Antiepileptic drugs; Piperidines; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Seizures

Most Recent Events

  • 21 Mar 2007 Discontinued - Clinical-Phase-Unknown for Seizures in China (unspecified route)
  • 13 Oct 1999 A study has been added to the adverse events and therapeutic trials sections
  • 13 Oct 1999 Investigation in Seizures in China (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top